A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation

Clinical trial NCT00372229 · COMPLETED

Trial details

NCT number: NCT00372229
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cytomegalovirus Infections

Start date: 2006-05-01
Primary completion: 2015-10-01
Enrollment: 299

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.